Hans Hull

Track

Insider profile

Currently holds a position at Pliant Therapeutics Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Business Officer Pliant Therapeutics Inc None -
Senior Vice President - Business Operations Adverum Biotechnologies Inc Dec. 9, 2015 - Feb. 12, 2016
Interim President and Chief Executive Officer Adverum Biotechnologies Inc July 23, 2015 - Dec. 9, 2015
Senior Vice President - Legal and Corporate Development Adverum Biotechnologies Inc July 1, 2014 - July 23, 2015
Vice President of Legal and Corporate Development Adverum Biotechnologies Inc Jan. 1, 2011 - July 1, 2014
Hans Hull's trades of Pliant Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
18.90
Quantity 34,919
Value US$659,969
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-22 2025-01-17
PlS Planned sale
58,798 +31.7%
206.39
US$1,063,045 		58,798 +31.7% 206.39 US$1,063,045
2024-07-12 2024-07-10
PlS Planned sale
90,057 -23.0%
213.03
US$1,113,484 		90,057 -23.0% 213.03 US$1,113,484
2024-01-19 2024-01-17
PlS Planned sale
43,946 +7.0%
405.47
US$3,176,564 		43,946 +7.0% 405.47 US$3,176,564
2023-08-07 2023-08-04
PlS Planned sale
20,050 -9.3%
20.01
US$401,200 		20,050 -9.3% 20.01 US$401,200
2023-08-07 2023-08-03
PlS Planned sale
13,069 -6.0%
20.00
US$261,380 		13,069 -6.0% 20.00 US$261,380
2023-08-03 2023-08-03
PrS Proposed sale
34,919
18.90
US$659,969 		34,919 18.90 US$659,969
2023-07-19 2023-07-17
PlS Planned sale
17,937 -7.6%
18.01
US$323,029 		17,937 -7.6% 18.01 US$323,029
2023-04-03 2023-03-30
PlS Planned sale
9,036 -4.3%
26.52
US$239,643 		9,036 -4.3% 26.52 US$239,643
2022-12-21 2022-12-20
S Sale
8,748 -6.0%
19.10
US$167,108 		8,748 -6.0% 19.10 US$167,108